336 related articles for article (PubMed ID: 30327855)
21. The Utility of Whole Body
Giudicatti L; Marangou J; Nolan D; Dembo L; Baumwol J; Dwivedi G
Heart Lung Circ; 2020 Jan; 29(1):e1-e6. PubMed ID: 31501049
[TBL] [Abstract][Full Text] [Related]
22. Intratumoral heterogeneity in
Molina-García D; García-Vicente AM; Pérez-Beteta J; Amo-Salas M; Martínez-González A; Tello-Galán MJ; Soriano-Castrejón Á; Pérez-García VM
Ann Nucl Med; 2018 Jul; 32(6):379-388. PubMed ID: 29869770
[TBL] [Abstract][Full Text] [Related]
23. Texture analysis on (18)F-FDG PET/CT images to differentiate malignant and benign bone and soft-tissue lesions.
Xu R; Kido S; Suga K; Hirano Y; Tachibana R; Muramatsu K; Chagawa K; Tanaka S
Ann Nucl Med; 2014 Nov; 28(9):926-35. PubMed ID: 25107363
[TBL] [Abstract][Full Text] [Related]
24. Visual findings of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in patients with cardiac sarcoidosis.
Ito K; Okazaki O; Morooka M; Kubota K; Minamimoto R; Hiroe M
Intern Med; 2014; 53(18):2041-9. PubMed ID: 25224185
[TBL] [Abstract][Full Text] [Related]
25.
Wang T; Sun H; Guo Y; Zou L
Mol Imaging; 2019; 18():1536012119856965. PubMed ID: 31198089
[TBL] [Abstract][Full Text] [Related]
26. Quantitative CT density histogram values and standardized uptake values of FDG-PET/CT with respiratory gating can distinguish solid adenocarcinomas from squamous cell carcinomas of the lung.
Tsubakimoto M; Yamashiro T; Tamashiro Y; Murayama S
Eur J Radiol; 2018 Mar; 100():108-115. PubMed ID: 29496067
[TBL] [Abstract][Full Text] [Related]
27.
Furuya S; Naya M; Manabe O; Hirata K; Ohira H; Aikawa T; Koyanagawa K; Magota K; Tsujino I; Anzai T; Kuge Y; Oyama-Manabe N; Kudo K; Shiga T; Tamaki N
J Nucl Cardiol; 2021 Oct; 28(5):2141-2148. PubMed ID: 31820409
[TBL] [Abstract][Full Text] [Related]
28. Impact of Image Reconstruction Settings on Texture Features in 18F-FDG PET.
Yan J; Chu-Shern JL; Loi HY; Khor LK; Sinha AK; Quek ST; Tham IW; Townsend D
J Nucl Med; 2015 Nov; 56(11):1667-73. PubMed ID: 26229145
[TBL] [Abstract][Full Text] [Related]
29. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
30. Texture analysis of acute myocardial infarction with CT: First experience study.
Hinzpeter R; Wagner MW; Wurnig MC; Seifert B; Manka R; Alkadhi H
PLoS One; 2017; 12(11):e0186876. PubMed ID: 29095833
[TBL] [Abstract][Full Text] [Related]
31. Diagnostic value of quantitative assessment of cardiac
Lebasnier A; Legallois D; Bienvenu B; Bergot E; Desmonts C; Zalcman G; Agostini D; Manrique A
Ann Nucl Med; 2018 Jun; 32(5):319-327. PubMed ID: 29560563
[TBL] [Abstract][Full Text] [Related]
32. Comparison of (18)F-fluorodeoxyglucose positron emission tomography (FDG PET) and cardiac magnetic resonance (CMR) in corticosteroid-naive patients with conduction system disease due to cardiac sarcoidosis.
Ohira H; Birnie DH; Pena E; Bernick J; Mc Ardle B; Leung E; Wells GA; Yoshinaga K; Tsujino I; Sato T; Manabe O; Oyama-Manabe N; Nishimura M; Tamaki N; Dick A; Dennie C; Klein R; Renaud J; deKemp RA; Ruddy TD; Chow BJW; Davies R; Hessian R; Liu P; Beanlands RSB; Nery PB
Eur J Nucl Med Mol Imaging; 2016 Feb; 43(2):259-269. PubMed ID: 26359191
[TBL] [Abstract][Full Text] [Related]
33. Heterogeneous myocardial FDG uptake and the disease activity in cardiac sarcoidosis.
Tahara N; Tahara A; Nitta Y; Kodama N; Mizoguchi M; Kaida H; Baba K; Ishibashi M; Hayabuchi N; Narula J; Imaizumi T
JACC Cardiovasc Imaging; 2010 Dec; 3(12):1219-28. PubMed ID: 21163450
[TBL] [Abstract][Full Text] [Related]
34. Clinical utility of texture analysis of 18F-FDG PET/CT in patients with Stage I lung cancer treated with stereotactic body radiotherapy.
Takeda K; Takanami K; Shirata Y; Yamamoto T; Takahashi N; Ito K; Takase K; Jingu K
J Radiat Res; 2017 Nov; 58(6):862-869. PubMed ID: 29036692
[TBL] [Abstract][Full Text] [Related]
35. Role of Textural Analysis of Pretreatment
Mishra A; Ravina M; Kote R; Kumar A; Kashyap Y; Dasgupta S; Reddy M
Indian J Nucl Med; 2023; 38(3):255-263. PubMed ID: 38046976
[TBL] [Abstract][Full Text] [Related]
36. Robustness of Radiomic Features in [
Lu L; Lv W; Jiang J; Ma J; Feng Q; Rahmim A; Chen W
Mol Imaging Biol; 2016 Dec; 18(6):935-945. PubMed ID: 27324369
[TBL] [Abstract][Full Text] [Related]
37. Predicting Response to Neoadjuvant Chemoradiotherapy in Esophageal Cancer with Textural Features Derived from Pretreatment
Beukinga RJ; Hulshoff JB; van Dijk LV; Muijs CT; Burgerhof JGM; Kats-Ugurlu G; Slart RHJA; Slump CH; Mul VEM; Plukker JTM
J Nucl Med; 2017 May; 58(5):723-729. PubMed ID: 27738011
[TBL] [Abstract][Full Text] [Related]
38. Heterogeneity of myocardial 2-[18F]fluoro-2-deoxy-D-glucose uptake is a typical feature in cardiac sarcoidosis: a study of 231 patients.
Schildt JV; Loimaala AJ; Hippeläinen ET; Ahonen AA
Eur Heart J Cardiovasc Imaging; 2018 Mar; 19(3):293-298. PubMed ID: 28950301
[TBL] [Abstract][Full Text] [Related]
39. The response of FDG uptake to immunosuppressive treatment on FDG PET/CT imaging for cardiac sarcoidosis.
Ahmadian A; Pawar S; Govender P; Berman J; Ruberg FL; Miller EJ
J Nucl Cardiol; 2017 Apr; 24(2):413-424. PubMed ID: 27457527
[TBL] [Abstract][Full Text] [Related]
40. FDG-PET/CT and rest myocardial perfusion imaging to predict high-degree atrioventricular block recovery in cardiac sarcoidosis.
Lucinian YA; Martineau P; Poenaru R; Tremblay-Gravel M; Cadrin-Tourigny J; Harel F; Pelletier-Galarneau M
J Nucl Cardiol; 2023 Dec; 30(6):2490-2500. PubMed ID: 37258950
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]